The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.
Age-related macular degeneration (AMD) is the primary cause of vision loss in elderly people of western European ancestry. Genetic, dietary, and environmental factors affect tissue concentrations of macular xanthophylls (MXs) within retinal cell types manifesting AMD pathology. In this article we review the history and state of science on the putative role of the MXs (lutein, zeaxanthin, and meso-zeaxanthin) in AMD and report findings on AMD-associated genes encoding enzymes, transporters, ligands, and receptors affecting or affected by MXs. We then use this context to discuss emerging research opportunities that offer promise for meaningful investigation and inference in the field.
National Eye Institute, Clinical Trials Branch, Bethesda, MD 20892-1863, USA. jpsangio@post.harvard.edu
John Paul
JP
SanGiovanni
Martha
M
Neuringer
D000818:Animals; D006801:Humans; D014975:Lutein / Q000494:pharmacology*; D008268:Macular Degeneration / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*; D012160:Retina / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D057170:Translational Research, Biomedical / Q000379:methods; D024341:Xanthophylls / Q000494:pharmacology*; D065146:Zeaxanthins
D024341:Xanthophylls; D065146:Zeaxanthins; C584722:meso-zeaxanthin; D014975:Lutein